Photodynamic Therapy Versus Eplerenone: Treatment Trial for Chronic Central Serous Chorioretinopathy

NCT03079141 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

107

Enrollment

OTHER

Sponsor class

Conditions

Chronic Central Serous Chorioretinopathy

Interventions

DRUG: Eplerenone
OTHER: Photodynamic therapy

Sponsor

Leiden University Medical Center

Collaborators

[object Object]
[object Object]